Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2020

View Archived Issues

AD and HHV: Still a mystery

Glial cells contribute to brain control of aging

New phase III trial evaluates MK-6482 in advanced renal cell carcinoma

Genetic removal of mast cell Tph1 protects mice from developing obesity and insulin resistance

FDA approves Dificid for C. difficile infection in children age 6 months and older

FDA clears NeoImmuneTech's IND to study NT-I7 plus pembrolizumab in advanced solid tumors

Otsuka reports promising topline data from Japanese trials of fremanezumab in migraine

LNA-anti-miR-150 ameliorates FSGS in vivo

Targeting SK1 overcomes resistance to immune checkpoint inhibitors in melanoma

Retinoic X receptor as therapeutic target for poststroke recovery

Vallon Pharmaceuitcals presents results on manipulated dextroamphetamine sulfate

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Gilead describes new IDO-1 inhibitors

Novartis Inflammasome Research describes new NLRP3 inflammasome inhibitors

New CRLF2 ligands identified at Korea University Research and Business Foundation

GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine

FDA approves Trijardy XR for type 2 diabetes

miR-3064-5p found to have prognostic value in HCC

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Sichuan Kelun-Biotech Biopharmaceutical discloses RORC agonists

FDA clears INDs for Surface Oncology's antibody candidates SRF-617 and SRF-388

Study suggests direct amino acid toxicity could account for caloric restriction benefits

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...